Inhatarget Therapeutics (Private limited company)
Inhatarget Therapeutics is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 0732.994.752. It was founded on 29-08-2019. Its registered office is in Charleroi. Its main activity is: Scientific research and development. Its annual accounts for 2025 report equity of € 1 568 763 and a loss of € 921 288. These accounts report 5.2 full-time equivalents. Addrly gives it a financial health grade of A, on a scale from A (safest) to E (most at risk). It filed its annual accounts within the legal deadline for each of its last 4 financial years.
Information last updated on 16-10-2026.
Company information
Key figures of Inhatarget Therapeutics
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
Profit / lossiWhat the period earned after taxes. A negative amount is a loss. | € -921 288-11 % | € -832 636+10 % | € -922 680+40 % | € -1 548 731 |
EquityiWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company. | € 1 568 763-28 % | € 2 164 146-27 % | € 2 975 679-23 % | € 3 841 043 |
Total assetsiEverything the company owns. Equal to total equity and liabilities, which says how it is financed. | € 2 156 542-27 % | € 2 957 294-17 % | € 3 554 356-21 % | € 4 501 511 |
Gross marginiSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else. | € 231 962+247 % | € 66 753-11 % | € 74 708-60 % | € 186 626 |
Employees (FTE)iAverage number of workers over the period, in full-time equivalents. | 5.2-10 % | 5.8+5 % | 5.5-8 % | 6 |
Financial estimate
- 3 Shareholders
- 4 Board links
Similar companies
Other companies in the same activity in Charleroi.
| Company | Town |
|---|---|
| HENOGEN | 6041 Charleroi |
| ENDO TOOLS THERAPEUTICS | 6041 Charleroi |
| BIO.BE | 6041 Charleroi |
| Santero Therapeutics | 6041 Charleroi |
| OGECO | 6041 Charleroi |
| Brussels South Charleroi BioPark Dev | 6041 Charleroi |
| DNAVision | 6041 Charleroi |
| VIRIDAXIS | 6041 Charleroi |
Frequently asked questions
Is Inhatarget Therapeutics still active? Yes. The Crossroads Bank for Enterprises lists Inhatarget Therapeutics as active.
What is the VAT number of Inhatarget Therapeutics? The VAT number of Inhatarget Therapeutics is BE 0732.994.752.
When was Inhatarget Therapeutics founded? Inhatarget Therapeutics was founded on 29-08-2019.
What is the address of Inhatarget Therapeutics? The current registered office of Inhatarget Therapeutics is Rue Antoine de Saint-Exupéry 2, 6041 Charleroi.
When did Inhatarget Therapeutics last file annual accounts? The latest annual accounts of Inhatarget Therapeutics were filed on 24-06-2026.
Does Inhatarget Therapeutics file its annual accounts on time? Yes. Inhatarget Therapeutics filed its annual accounts within the legal deadline for each of its last 4 financial years.
How many employees does Inhatarget Therapeutics have? Inhatarget Therapeutics employs 5.2 full-time equivalents according to its most recent annual accounts.
Is Inhatarget Therapeutics financially healthy? Addrly gives Inhatarget Therapeutics a financial health grade of A, on a scale from A (safest) to E (most at risk). The failure probability and the indicators behind it are visible with a free account.
Is Inhatarget Therapeutics profitable? The annual accounts of Inhatarget Therapeutics for 2025 show a loss of € 921 288.
What is the equity of Inhatarget Therapeutics? The equity of Inhatarget Therapeutics was € 1 568 763 at the close of the 2025 financial year.
Who are the directors of Inhatarget Therapeutics? The annual accounts of Inhatarget Therapeutics record 7 mandates. The names, roles and dates are visible with a free account.
Can Inhatarget Therapeutics receive Peppol e-invoices? Yes. Inhatarget Therapeutics is registered on the Peppol network and can receive structured electronic invoices.
What does Inhatarget Therapeutics do? The main activity of Inhatarget Therapeutics is: Scientific research and development.